Virbac SA Total Liabilities
Virbac SA total liabilities. Based on the latest financial reports, Virbac SA (VIRP) has total liabilities worth €750.28 Million EUR (≈ $877.16 Million USD) as of June 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Check VIRP financial resilience to evaluate the company's liquid asset resilience ratio.
Total Liabilities of Virbac SA (2002–2024)
Total liabilities of Virbac SA from 2002 to 2024. This chart illustrates how Virbac SA's total liabilities have evolved over time, based on quarterly financial data. Explore VIRP long-term investment intensity to see how much of total assets are deployed in long-term investments.
Virbac SA Competitors by Total Liabilities
The table below lists competitors of Virbac SA ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Xiangcai Co Ltd
SHG:600095
|
China | CN¥37.26 Billion |
|
National Storage REIT
AU:NSR
|
Australia | AU$2.49 Billion |
|
AIR CHINA LTD H ADR/20
F:AD2B
|
Germany | €303.54 Billion |
|
SSAB AB (publ)
ST:SSAB-A
|
Sweden | Skr38.39 Billion |
|
China South Publishing & Media Group Co Ltd
SHG:601098
|
China | CN¥9.59 Billion |
|
Vidrala SA
MC:VID
|
Spain | €1.05 Billion |
|
Ondas Holdings Inc.
NASDAQ:ONDS
|
USA | $1.42 Billion |
|
Gerdau S.A
SA:GGBR3
|
Brazil | R$28.08 Billion |
Liability Composition Analysis (2002–2024)
This chart breaks down Virbac SA's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the complete balance sheet picture, see Virbac SA asset portfolio.
Liquidity & Leverage Metrics
Virbac SA Total Liabilities Ratios Explained
Virbac SA total liabilities ratios compare its liabilities with its current assets, cash and shareholder equity.
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 1.96 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.70 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.41 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Virbac SA's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Virbac SA (2002–2024)
The table below shows the annual total liabilities of Virbac SA from 2002 to 2024.
| Year | Total Liabilities | Change |
|---|---|---|
| 2024-12-31 | €805.12 Million ≈ $941.27 Million |
+47.51% |
| 2023-12-31 | €545.81 Million ≈ $638.11 Million |
+4.73% |
| 2022-12-31 | €521.17 Million ≈ $609.30 Million |
+4.48% |
| 2021-12-31 | €498.84 Million ≈ $583.19 Million |
+9.81% |
| 2020-12-31 | €454.28 Million ≈ $531.11 Million |
-41.11% |
| 2019-12-31 | €771.38 Million ≈ $901.82 Million |
-0.71% |
| 2018-12-31 | €776.93 Million ≈ $908.32 Million |
-2.70% |
| 2017-12-31 | €798.49 Million ≈ $933.52 Million |
-10.92% |
| 2016-12-31 | €896.37 Million ≈ $1.05 Billion |
-5.47% |
| 2015-12-31 | €948.26 Million ≈ $1.11 Billion |
+12.40% |
| 2014-12-31 | €843.65 Million ≈ $986.32 Million |
+75.08% |
| 2013-12-31 | €481.86 Million ≈ $563.34 Million |
+12.25% |
| 2012-12-31 | €429.28 Million ≈ $501.88 Million |
+56.23% |
| 2011-12-31 | €274.77 Million ≈ $321.23 Million |
+18.74% |
| 2010-12-31 | €231.40 Million ≈ $270.53 Million |
+16.71% |
| 2009-12-31 | €198.27 Million ≈ $231.80 Million |
-6.32% |
| 2008-12-31 | €211.64 Million ≈ $247.43 Million |
+10.03% |
| 2007-12-31 | €192.35 Million ≈ $224.88 Million |
-10.09% |
| 2006-12-31 | €213.94 Million ≈ $250.11 Million |
+38.80% |
| 2005-12-31 | €154.14 Million ≈ $180.20 Million |
-5.42% |
| 2004-12-31 | €162.96 Million ≈ $190.52 Million |
+4.31% |
| 2003-12-31 | €156.23 Million ≈ $182.65 Million |
+16.39% |
| 2002-12-31 | €134.22 Million ≈ $156.92 Million |
-- |
About Virbac SA
Virbac SA manufactures and sells a range of products and services for companion and farm animals in Europe, North America, Latin America, East Asia, India, Africa, the Middle East, and the Pacific. The company offers a range of vaccines, antibiotics, parasiticides, and anti-inflammatory drugs, as well as dermatology, dental, specialty, diagnosis, nutrition, petfood, and pharmaceutical products. I… Read more